幽门螺杆菌
荟萃分析
养生
癌症
医学
淋巴瘤
重症监护医学
胃肠病学
内科学
作者
Rong Lin,Jing Li,Huiying Shi,Feng Zhou,Li Xie
标识
DOI:10.37766/inplasy2021.11.0089
摘要
Review question / Objective: To explore the effectiveness and safety of eradication therapies (including first-and rescue eradication therapy) for Chinese patients with Hp infection.Condition being studied: Helicobacter Pylori (Hp) infection is involved in the development of gastric malignancies, particularly gastric cancer and gastric mucosa-associated lymphoid tissue lymphoma.With the prevalence of antibiotic resistance in Helicobacter pylori (Hp) globally, to identify a more effective treatment regimen on the eradication of Hp becomes high priority for clinicians.There are several some network meta-analyses investigating the effectiveness and safety of various regimens for Hp eradication treatment worldwide, however, the findings cannot reflect the certain circumstances in China.
科研通智能强力驱动
Strongly Powered by AbleSci AI